<SEC-DOCUMENT>0001104659-22-074662.txt : 20220627
<SEC-HEADER>0001104659-22-074662.hdr.sgml : 20220627
<ACCEPTANCE-DATETIME>20220627135740
ACCESSION NUMBER:		0001104659-22-074662
CONFORMED SUBMISSION TYPE:	6-K
PUBLIC DOCUMENT COUNT:		3
CONFORMED PERIOD OF REPORT:	20220627
FILED AS OF DATE:		20220627
DATE AS OF CHANGE:		20220627

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Bioceres Crop Solutions Corp.
		CENTRAL INDEX KEY:			0001769484
		STANDARD INDUSTRIAL CLASSIFICATION:	AGRICULTURE CHEMICALS [2870]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			E9
		FISCAL YEAR END:			0630

	FILING VALUES:
		FORM TYPE:		6-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-38836
		FILM NUMBER:		221043813

	BUSINESS ADDRESS:	
		STREET 1:		PO BOX 309, UGLAND HOUSE
		CITY:			GEORGE TOWN, GRAND CAYMAN
		STATE:			E9
		ZIP:			KY1-1104
		BUSINESS PHONE:		54 341 486 1122

	MAIL ADDRESS:	
		STREET 1:		OCAMPO 210 BIS, PREDIO CCT
		CITY:			ROSARIO
		STATE:			C1
		ZIP:			2000
</SEC-HEADER>
<DOCUMENT>
<TYPE>6-K
<SEQUENCE>1
<FILENAME>tm2219491d1_6k.htm
<DESCRIPTION>FORM 6-K
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Rule-Page --><DIV STYLE="width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 2pt solid; border-bottom: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="margin: 0">&nbsp;</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>UNITED STATES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SECURITIES AND EXCHANGE COMMISSION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Washington, D.C. 20549</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Form&nbsp;6-K</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Report of Foreign Private Issuer</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Pursuant to Rules&nbsp;13a-16 or 15d-16 under</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>the Securities Exchange Act of 1934</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>For the month of June&nbsp;2022</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Commission File Number: 001-38836</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 14pt"><B>BIOCERES CROP
SOLUTIONS CORP.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Translation of registrant&rsquo;s name into English)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Ocampo 210 bis, Predio CCT, Rosario</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Province of Santa Fe, Argentina</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Address of principal executive offices)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Indicate by check mark whether the registrant files or will file annual
reports under cover Form&nbsp;20-F or Form&nbsp;40-F.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form&nbsp;20-F&nbsp;&nbsp;</FONT><FONT STYLE="font-family: Wingdings">&#120;</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
Form&nbsp;40-F&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-family: Wingdings">&#168;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark if the registrant is submitting the Form&nbsp;6-K in paper as permitted by Regulation S-T Rule&nbsp;101(b)(1): <FONT STYLE="font-family: Wingdings">&#168;</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark if the registrant is submitting the Form&nbsp;6-K in paper as permitted by Regulation S-T Rule&nbsp;101(b)(7): <FONT STYLE="font-family: Wingdings">&#168;</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Rule-Page --><DIV STYLE="width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; border-bottom: Black 2pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Exhibit&nbsp;List</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: Black 1pt solid; padding-bottom: 1pt; padding-right: 5.4pt; padding-left: 0.1in; font-size: 10pt; text-indent: -0.1in; width: 8%"><B>Exhibit&nbsp;No.</B></TD>
    <TD STYLE="padding-bottom: 1pt; width: 2%">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 0.1in; font-size: 10pt; text-indent: -0.1in; width: 90%"><B>Description</B></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 0.1in; font-size: 10pt; text-indent: -0.1in"><A HREF="tm2219491d1_ex99-1.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">99.1</FONT></A></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 0.1in; font-size: 10pt; text-indent: -0.1in"><A HREF="tm2219491d1_ex99-1.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Press release, Bioceres Crop Solutions Corp. announces that FDA Favorably Concludes HB4&reg; Wheat Food and Feed Safety Evaluation</FONT></A></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SIGNATURES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Pursuant to the requirements of the Securities Exchange Act of 1934,
the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">BIOCERES CROP SOLUTIONS CORP.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Registrant)</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%">&nbsp;</TD>
    <TD STYLE="width: 4%">&nbsp;</TD>
    <TD STYLE="width: 5%">&nbsp;</TD>
    <TD STYLE="width: 41%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dated: June&nbsp;27, 2022</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Federico Trucco</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name: </FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Federico Trucco</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Executive Officer</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 3; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>tm2219491d1_ex99-1.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: right; margin: 0"><B>Exhibit 99.1</B></P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0"><IMG SRC="tm2219491d1_ex99-1img001.jpg" ALT="">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 14pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>FDA Favorably Concludes HB4&reg; Wheat Food
and Feed Safety Evaluation</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>ROSARIO,
Argentina &ndash; June&nbsp;27, 2022 &ndash; </B><U>Bioceres Crop Solutions Corp</U><FONT STYLE="color: blue">.</FONT></FONT> (&ldquo;Bioceres&rdquo;
or the &ldquo;Company&rdquo;) (NASDAQ: BIOX), a fully integrated provider of crop productivity solutions designed to enable the transition
of agriculture towards carbon neutrality, announced today that the U.S. Food and Drug Administration (FDA) has concluded its evaluation
of the Company&acute;s proprietary drought-tolerant HB4&reg; Wheat.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Upon review of all the safety and regulatory information
submitted, the FDA has concluded that it has no further questions regarding the safety of HB4&reg; Wheat, and that it does not raise issues
that would require premarket review or approval by FDA. The conclusion of this voluntary consultation program is a key step towards commercial
enablement in the United States, which is awaiting approval from the U.S. Department of Agriculture (USDA).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">The
United States is the fifth largest wheat producer, with an average of 15 million hectares planted every year, and the third largest exporter,
holding a key position in the global wheat trade. The FDA&acute;s conclusion follows recent approvals by Brazil, Colombia, Australia,
and New Zealand for use in food and feed. HB4</FONT>&reg; Wheat is commercially authorized for production and consumption in Argentina,
where five varieties have been cleared for registration in the current crop season.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">HB4</FONT>&reg;
drought-tolerance technology has been shown to increase wheat yields by an average of 20% in water-limited conditions, a key adaptation
that favors double-cropping systems, where water management is increasingly critical. Under no-till practices, HB4&reg; Soy-Wheat rotations
result in an estimated 1,650 kg of carbon fixed into the soil per hectare per year, compared to positive emissions from conventional soy
monoculture.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>About Bioceres Crop Solutions Corp.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Bioceres
Crop Solutions Corp. (NASDAQ: BIOX) is a fully integrated provider of crop productivity technologies designed to enable the transition
of agriculture towards carbon neutrality. To do this, Bioceres&rsquo; solutions create economic incentives for farmers and other stakeholders
to adopt environmentally friendlier production practices. The Company has a unique biotech platform with high-impact, patented technologies
for seeds and microbial ag-inputs, as well as next generation crop nutrition and protection solutions. Through its HB4&reg; program,
the Company is bringing digital solutions to support growers&rsquo; decisions and provide end-to-end traceability for production outputs.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="font-size: 10pt; margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><IMG SRC="tm2219491d1_ex99-1img001.jpg" ALT="">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Forward-looking statements</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">This communication includes &ldquo;forward-looking
statements&rdquo; within the meaning of the &ldquo;safe harbor&rdquo; provisions of the United States Private Securities Litigation Reform
Act of 1995. Forward-looking statements may be identified by the use of words such as &ldquo;forecast,&rdquo; &ldquo;intend,&rdquo; &ldquo;seek,&rdquo;
 &ldquo;target,&rdquo; &ldquo;anticipate,&rdquo; &ldquo;believe,&rdquo; &ldquo;expect,&rdquo; &ldquo;estimate,&rdquo; &ldquo;plan,&rdquo;
 &ldquo;outlook,&rdquo; and &ldquo;project&rdquo; and other similar expressions that predict or indicate future events or trends or that
are not statements of historical matters. Such forward-looking statements are based on management&rsquo;s reasonable current assumptions,
expectations, plans and forecasts regarding the Company&rsquo;s current or future results and future business and economic conditions
more generally. Such forward-looking statements involve risks, uncertainties and other factors, which may cause the actual results, levels
of activity, performance or achievement of the Company to be materially different from any future results expressed or implied by such
forward-looking statements, and there can be no assurance that actual results will not differ materially from management&rsquo;s expectations
or could affect the Company&rsquo;s ability to achieve its strategic goals, including the uncertainties relating to the impact of COVID-19
on the Company&rsquo;s business, operations, liquidity and financial results and the other factors that are described in the sections
entitled &ldquo;Risk Factors&rdquo; in the Company's Securities and Exchange Commission filings updated from time to time. The preceding
list is not intended to be an exhaustive list of all of our forward-looking statements. Therefore, you should not rely on any of these
forward-looking statements as predictions of future events. All forward-looking statements contained in this release are qualified in
their entirety by this cautionary statement. Forward-looking statements speak only as of the date they are or were made, and the Company
does not intend to update or otherwise revise the forward-looking statements to reflect events or circumstances after the date of this
release or to reflect the occurrence of unanticipated events, except as required by law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: #FEFEFE"><B>Contacts</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Investor Relations Contact</B><BR>
Chris Tyson&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Executive Vice President&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">MZ Group &ndash; MZ North America&nbsp;<BR>
(949) 491-8235&nbsp;</P>

<P STYLE="text-decoration: underline; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">BIOX@mzgroup.us<BR>
www.mzgroup.us</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: #FEFEFE"><B>Bioceres Crop Solutions</B>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Paula Savanti<BR>
Head of Investor Relations<BR>
<U>investorrelations@biocerescrops.com</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 2; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>tm2219491d1_ex99-1img001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm2219491d1_ex99-1img001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" !Y + # 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#W^BBB@ HH
MHH **** "BBB@ HHHH **I:AJ$&G6S33.!@?*N>6/H*Y:P\53B_)N_\ CWE/
M _N=N*Y:V,I49J$GJ_P]27))V9VU%1Q2I+&'1@RD9!!SFI*Z4[E!1113 ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "J>I:C#IMFUQ,?E'  ZL?2KAKB
M_%?GW^M66EP@X*[^/<GG\ #^=1-M1]W<SJSY(W6Y5M[>[\4ZDUQ*3';*<>P'
MH/>I_$%UI:VR:=:Q>9-'PC)_"?ZT_4+EX)(?#VD95P )''OU_P 30\MCX?*6
MEG +S4SU;&<&N/ZLK-=7NSFYTD]?5^?9%/1-9GT6<6]Y&X@DP0&_A]Q7>HZR
M(K*05(R"/2O/-8M=8GM6O=2:-!&/E7(#<D< 5U?A2X:YT& L263*9^AX_3%;
M8>$J?N="Z-5\W(S;HHHKI.H**** "BBB@ HHHH **** "BBB@ HHHH ****
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MI0H)WII)^EBBFB6,>JOJ21$739RVX^F.G2EU/1K+5XU2[A#;?NL.&'XU=\Q
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M7?J.U.<>5I-?@9VE^'M.TB0R6L&)",%V))_#TI=3T#3M68/=0 R*,!U.UO\
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,H **** "BBB@#__9

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
